Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 07, 2020 16:01 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Provides Corporate Update

SOUTH SAN FRANCISCO, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced a reduction in workforce of approximately 30% of its head count to focus...
June 23, 2020 07:30 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Announces Clinical Update on Vecabrutinib Program

SOUTH SAN FRANCISCO, Calif., June 23, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that the Company will not advance its non-covalent BTK inhibitor...
May 07, 2020 16:05 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Reports First Quarter 2020 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the first quarter ended March 31, 2020. Loss from...
April 30, 2020 07:00 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals to Host Conference Call on May 7th to Discuss First Quarter 2020 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Thursday, May 7th, 2020 at 4:30...
March 10, 2020 16:05 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., March 10, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the fourth quarter and year ended December 31, 2019....
March 03, 2020 07:00 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals to Host Conference Call on March 10th to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., March 03, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Tuesday, March 10, 2020 at 4:30...
February 25, 2020 16:05 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals to Present at the 40th Annual Cowen Health Care Conference

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President,...
December 05, 2019 11:41 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Announces Data from Ongoing Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies

SOUTH SAN FRANCISCO, Calif., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced data from the Company’s Phase 1b/2 clinical trial of its non-covalent BTK...
November 12, 2019 16:05 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals Reports Third Quarter 2019 Financial Results and Recent Highlights

Phase 1b/2 Trial of Vecabrutinib in 400 mg Cohort; Clinical Update at Upcoming ASH Annual Meeting Sunesis to Host Conference Call Today at 4:30 PM Eastern Time SOUTH SAN FRANCISCO, Calif., Nov. ...
November 08, 2019 07:00 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals to Present at 28th Annual Credit Suisse Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 08, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President,...